Patent · US Active

Process for the manufacture of idalopirdine via hydrogenation of an imine

US9975850B2 · kind B2 · utility

0Cited by

1References

18Claims

0Family size

Assignee

H. LUNDBECK A/S · DK

Inventors

Mikkel Fog Jacobsen · Copenhagen, DK
Florian Huber · Grassau, DE

Key dates

Filing date	Apr 6, 2017
Grant date	May 22, 2018
Priority date	—
Expiry date	Apr 6, 2037

Classification

Technology area (CPC B)Performing Operations; Transporting
CPC primaryB01D3/36
WIPO fieldChemical engineering
WIPO sectorChemistry

Abstract

The present invention relates to the preparation of N-(2-(6-fluoro-1H-indol-3-yl)-ethyl)-3-(2,2,3,3-tetrafluoropropoxy)-benzylamine (Compound I), INN-name idalopirdine, and pharmaceutically acceptable salts thereof:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.